Breast Cancer Liquid Biopsy Market
According to Intent Market Research, the Breast Cancer Liquid Biopsy Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 14.7% to touch USD 2.9 billion by 2030. The Breast Cancer Liquid Biopsy Market is dominated by key players such as, NeoGenomics Laboratories, The Menarini Group, Thermo Fisher Scientific, Inc., Epic Sciences, Inc., and Biocept, Inc.